First self driving cars. Now self driving shopping carts coming to a Wal Mart near you. Roadmap includes $HOME $EXEL $ACIA $HLF $SRPT.
Long Watches: $SRPT, $HOME, $EXEL, $CYH, $HLF, $LVS! Short Watches: $CBRL, $AGIO!
Premarket most advanced stocks: $VTAE, $SRPT, $AERI, $ARRY, $XIV, $EXEL, $ACIA, $JASO, $USLV, $GOLD
Premarket most active stocks: $VTAE, $AAPL, $SRPT, $XIV, $TVIX, $QQQ, $EXEL, $ERIC, $VOD, $ASML
RT @ACInvestorBlog: Pre-market movers $VTAE $SRPT $AST $HOME $ARRY $GLUU $SSL $EGO $EXEL $HMY $ACIA $GOLD $CLVS
RT @Biotech_5: #Biotechs Premarket
$VTAE+158%
$SRPT+15%
$AERI+7.38%
$ARRY+4%
$EXEL+3.57%
$CLVS+1.79%
#Biotechs Premarket
$VTAE+158%
$SRPT+15%
$AERI+7.38%
$ARRY+4%
$EXEL+3.57%
$CLVS+1.79%
On The Fly: Pre-market Movers $SRPT $F $COH $MON $HLF $BAYRY $EXEL $VTAE $AGN $CBRL: Full Story https://t.co/UMYMM3hX3O
Pre-market movers $VTAE $SRPT $AST $HOME $ARRY $GLUU $SSL $EGO $EXEL $HMY $ACIA $GOLD $CLVS
A few stocks on charts so far today: $ARRY $AST $CYH $EXEL $GLUU $HOME $SRPT $TOPS all gapping up. #DayTrading
$SRPT, FDA critic of SRPT leaves .. $EXEL, drug approved by EU ... $AST, good test results #stocks #investing #tradeideas
DayTraders : Hot stocks to buy : $EXEL over 13.50$ $SRPT over 30$
Notable PreM Movers 09/14: (Up) $SRPT $HOME $ARRY $GLUU $JNUG $EXEL (Down) $JDST $AGIO $OAS $VXX
Watch Idea - Gappers: $SRPT $AAPL $GOLD $EXEL $ACIA $AVID $AMSC $F $AMSG $CBRL $AGN #stocks #trading #options -r
RT @Super1NYC: #Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN…
Benzinga: 12 Stocks Moving In Wednesday's #PreMarket Session https://t.co/uVuTBTZm2c $AGIO $AREX $ARRY $SRPT $HOME $GLUU $EXEL $ZBRA $HLF …
RT @Benzinga: 12 Stocks Moving In Wednesday's #PreMarket Session https://t.co/b8ZC7pWUtQ $AGIO $AREX $ARRY $SRPT $HOME $GLUU $EXEL $ZBRA $H…
12 Stocks Moving In Wednesday's #PreMarket Session https://t.co/b8ZC7pWUtQ $AGIO $AREX $ARRY $SRPT $HOME $GLUU $EXEL $ZBRA $HLF $CBRL $LFVN
$NWBO $AST $GBSN $SRPT $EXEL $AMDA $BTX $CRMD $CLRB $HNR $CHK $CLF #stockstowatch
RT @Super1NYC: #Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN…
$SRPT $EXEL $LVS $MON $DV $CCP and more. Morning briefing: Market news, upgrades/downgrades 9.14 https://t.co/ju631WEJci
RT @Super1NYC: #Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN…
RT @Super1NYC: #Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN…
RT @Super1NYC: #Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN…
#Premarket Top % Gainers: $SRPT 13%, $PTX 8%, $GLUU 7%, $HOME 6%, $PLUG, $ARRY, $UGAZ $SSL $CYH $NWBO $EXEL $EGO $HMY $GBSN $SVXY $GFI $NUGT
$EXEL and $XIV are significant Pre-Market Gainers this AM on SpeculatingStocks Pre-Market, https://t.co/ayAi1CAXh9
RT @ACInvestorBlog: Pre-market movers $VTAE $SRPT $AST $HOME $ARRY $GLUU $SSL $EGO $EXEL $HMY $ACIA $GOLD $CLVS
Popular: $VTAE, $AGN, $EXEL, $CXR.CA, $M, $LVS, $DV, $JJC, $ACAT
$EXEL, don't know how much wait EU approval is, obviously FDA approval is a bigger deal #stocks #investing #tradeideas
Main upcoming FDA events- Part II:
$EXEL-->cabozantinib+comibetinib
$MDVN-->Ph2 Terrain & Strive Studies
$CLDX-->CDX-011
Recent $EXEL technical alerts: New 52 Week High plus 3 more alerts... https://t.co/AiaNS7KXRt
Why EXEL Is UP In Premarket Trading Exelixis https://t.co/ki8zHDfR2c $EXEL
$EXEL:
Exelixis, Ipsen say EU approves kidney cancer drug:
https://t.co/Bdqoget5Ju
$EXEL Exelixis, Ipsen say EU approves kidney cancer drug https://t.co/DGHstbcyVp
Do you know that #WallStreet price for $EXEL is $10.67 https://t.co/c2IU5AaDZL
$exel $anf
Good Morning, $LCLP looking for a break and hold of .30 $IDDR on news watch.The rest of the market $GEVO $CRMD $NYMY $CANN $EXEL $GOLD GLTA
$EXEL Another milestone for company we told you about at $4.56 @ https://t.co/0NeE133bKX. ...https://t.co/tJ2p3cTGKm via @salphatrending
RT @Investor666: $EXEL European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carc...https…
$EXEL European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carc...https://t.co/zib4QAUih2
@adamfeuerstein $exel news
WatchList: 9.14.2016. $EXEL, $MYL, $TSRO, $SRPT.
#stocks #trading
$EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment
@THFH_Hedgie They all also called $EXEL a toxic turd at $1.25, printing over $13 today....
Obserwuje: $EXEL $ARRY $SRPT $HOME
Earnings: https://t.co/Y381w5I6Rx
#daytrading #trading #stocks
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
Watching: $EXEL $ARRY $SRPT $HOME
Earnings: https://t.co/oLBUe1v91A
#daytrading #trading #stocks
RT @shaneblackmon: $EXEL up 10% on this https://t.co/VkS7YdWRCv
Cant deny $EXEL has been a roar this year. It has constantly executed for its investors. A clear Winner here.
RT @Biotech_5: EC approves Cabometyx for advanced renal cell carcinoma following VEGF therapy $EXEL
$EXEL up 10% on this https://t.co/VkS7YdWRCv
RT @DayTradeWarrior: Learn a SIMPLE Day Trading Strategy for Reversals | https://t.co/o28wOjsQTB $TSO $EXEL $ADRO $VEEV $ARWR https://t.co/…
RT @DayTradeWarrior: Learn a SIMPLE Day Trading Strategy for Reversals | https://t.co/o28wOjsQTB $TSO $EXEL $ADRO $VEEV $ARWR https://t.co/…
RT @DayTradeWarrior: Learn a SIMPLE Day Trading Strategy for Reversals | https://t.co/o28wOjsQTB $TSO $EXEL $ADRO $VEEV $ARWR https://t.co/…
Learn a SIMPLE Day Trading Strategy for Reversals | https://t.co/o28wOjsQTB $TSO $EXEL $ADRO $VEEV $ARWR https://t.co/oEOOB06bUA
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @odibro: $EXEL EC Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted…
RT @Biotech_5: EC approves Cabometyx for advanced renal cell carcinoma following VEGF therapy $EXEL
$EXEL:
Exelixis’ Cabometyx approved in Europe for kidney cancer; shares …:
https://t.co/QRiE1FAtJm
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
$EXEL European Commission Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Rena... https://t.co/179OFtAMPq
EC approves Cabometyx for advanced renal cell carcinoma following VEGF therapy $EXEL
Exelixis' Cabometyx approved in Europe for kidney cancer; shares up 1% premarket https://t.co/23S7nxGWmK #premarket $EXEL $IPSEY $IPSEF
Exelixis' Cabometyx approved in Europe for kidney cancer; shares up 1% premarket https://t.co/L1as11tHsE #premarket $EXEL $IPSEY $IPSEF
Exelixis' Cabometyx approved in Europe for kidney cancer; shares up 1% premarket https://t.co/taOdDG2Ftg #premarket $EXEL $IPSEY $IPSEF
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @iciresearch: $EXEL EC Approves CABOMETYX (cabozantinib) Tablets for the Treatment of Advanced RCC https://t.co/YvKofAEdq3
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
$EXEL EC Approves CABOMETYX (cabozantinib) Tablets for the Treatment of Advanced RCC https://t.co/YvKofAEdq3
RT @sarcbot: $EXEL The buy out keeps getting more expensive. I say 30 now.....
RT @mikegoodma: $EXEL blows past 52 week high and consensus PT. +5.5% at $12.17/share
RT @odibro: Key #FDA Decisions and Trial Results Expected in October $EXEL $MDVN $CLDX $PTN $CERU $ANTH https://t.co/IlNRHxHo8Q
RT @Briefingcom: $EXEL: Exelixis receives EU approval for CABOMETYX tablets; triggers $60 million milestone payment https://t.co/zbF2hqbmcH
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
RT @BioStocks: $EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co…
$EXEL European Commission Approves CABOMETYX for the Treatment of Advanced RCC. Triggers $60M Milestone Payment https://t.co/KiomfxiEHY
RT @odibro: $EXEL EC Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted…
$EXEL:
Exelixis (EXEL) Receives EC Approval of CABOMETYX as RCC …:
https://t.co/oWiTjIuq8B
European Commission approves Canometyx (cabozantinib) tablets for the treatment of advanced RCC. $EXEL
RT @1MinuteStock: We calculated 21-day Expected Return of $EXEL for you: 16.47% https://t.co/46E2WrT12c
We calculated 21-day Expected Return of $EXEL for you: 16.47% https://t.co/46E2WrT12c
RT @Briefingcom: $EXEL: Exelixis receives EU approval for CABOMETYX tablets; triggers $60 million milestone payment https://t.co/zbF2hqbmcH
$EXEL: Exelixis receives EU approval for CABOMETYX tablets; triggers $60 million milestone payment https://t.co/zbF2hqbmcH
RT @1MinuteStock: Unicorn Bay rating for $EXEL is 2.13 out of 5. https://t.co/Lw8PCl4AEv
Unicorn Bay rating for $EXEL is 2.13 out of 5. https://t.co/Lw8PCl4AEv
RT @odibro: $EXEL EC Approves CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted…
RT @1MinuteStock: We calculated 63-day Expected Return of $EXEL for you: 72.91% https://t.co/46E2WrBpDC
We calculated 63-day Expected Return of $EXEL for you: 72.91% https://t.co/46E2WrBpDC
RT @1MinuteStock: Wondering about #sentiment indicator for $EXEL? The Short Ratio is 5.88% https://t.co/vDRVsg5cSm
Stocks in play miércoles 14 de septiembre 2016:
$AAPL $FB $NUGT $TWTR $VRX $MON $SRPT $EXEL $UVXY $JNUG $FCX $F... https://t.co/9yjvsbi7pc
#Premarket Top % Gainers: $VTAE 157%, $SRPT 16%, $BLFS 13%, $SPEX 8%, $AST 7%, $AERI $HOME $PLUG $HTBX $NWBO $PTX $SSL $EXEL $CYH $EGO $VG
#Premarket ― UPSIDE pre-mkt: $VTAE, $SRPT, $AERI, $CYH, $SSL, $VG, $HLF, $GFI, $EXEL, $M powered by https://t.co/falN7dd2ju
#Watchlist #daytrading 14-09-2016
$SRPT $BLFS $HOME $TOT $EXEL $AAPL $AST https://t.co/VkQny3OKXm
RT @CBOE: UPSIDE pre-mkt: $VTAE, $SRPT, $AERI, $CYH, $SSL, $VG, $HLF, $GFI, $EXEL, $M powered by https://t.co/scoWUQ48H7 https://t.co/3qp58…
UPSIDE pre-mkt: $VTAE, $SRPT, $AERI, $CYH, $SSL, $VG, $HLF, $GFI, $EXEL, $M powered by https://t.co/scoWUQ48H7 https://t.co/3qp58kmLla
RT @CBOE: UPSIDE pre-mkt: $VTAE, $SRPT, $AERI, $CYH, $SSL, $VG, $HLF, $GFI, $EXEL, $M powered by https://t.co/scoWUQ48H7 https://t.co/3qp58…
RT @Super1NYC: #Premarket Top % Gainers: $VTAE 157%, $SRPT 16%, $BLFS 13%, $SPEX 8%, $AST 7%, $AERI $HOME $PLUG $HTBX $NWBO $PTX $SSL $EXEL…
Why These Stocks Are Up https://t.co/u7cytzhjxd $AERI $AAPL $ARRY $AST $HOME $COMM $CYH $ED $DV $EGO $EXK $ESV $EXEL $FFIV
RT @BruceTennen: First self driving cars. Now self driving shopping carts coming to a Wal Mart near you. Roadmap includes $HOME $EXEL $ACIA…
$EXEL says European commission approves Cabometyx https://t.co/mRaTeNWPyD
$EXEL The buy out keeps getting more expensive. I say 30 now.....
RT @Super1NYC: #Premarket Top % Gainers: $VTAE 157%, $SRPT 16%, $BLFS 13%, $SPEX 8%, $AST 7%, $AERI $HOME $PLUG $HTBX $NWBO $PTX $SSL $EXEL…